The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies
Open accessAbstract
BACKGROUND: Endometriosis is a risk factor for epithelial ovarian cancer; however, whether this risk extends to all invasive histological subtypes or borderline tumours is not clear. We undertook an international collaborative study to assess the association between endometriosis and histological subtypes of ovarian cancer. METHODS: Data from 13 ovarian cancer case-control studies, which were part of the Ovarian Cancer Association Consortium, were pooled and logistic regression analyses were undertaken to assess the association between self-reported endometriosis and risk of ovarian cancer. Analyses of invasive cases were done with respect to histological subtypes, grade, and stage, and analyses of borderline tumours by histological subtype. Age, ethnic origin, study site, parity, and duration of oral contraceptive use were included in all analytical models. FINDINGS: 13 226 controls and 7911 women with invasive ovarian cancer were included in this analysis. 818 and 738, respectively, reported a history of endometriosis. 1907 women with borderline ovarian cancer were also included in the analysis, and 168 of these reported a history of endometriosis. Self-reported endometriosis was associated with a significantly increased risk of clear-cell (136 [20·2%] of 674 cases vs 818 [6·2%] of 13 226 controls, odds ratio 3·05, 95% CI 2·43-3·84, p<0·0001), low-grade serous (31 [9·2%] of 336 cases, 2·11, 1·39-3·20, p<0·0001), and endometrioid invasive ovarian cancers (169 [13·9%] of 1220 cases, 2·04, 1·67-2·48, p<0·0001). No association was noted between endometriosis and risk of mucinous (31 [6·0%] of 516 cases, 1·02, 0·69-1·50, p=0·93) or high-grade serous invasive ovarian cancer (261 [7·1%] of 3659 cases, 1·13, 0·97-1·32, p=0·13), or borderline tumours of either subtype (serous 103 [9·0%] of 1140 cases, 1·20, 0·95-1·52, p=0·12, and mucinous 65 [8·5%] of 767 cases, 1·12, 0·84-1·48, p=0·45). INTERPRETATION: Clinicians should be aware of the increased risk of specific subtypes of ovarian cancer in women with endometriosis. Future efforts should focus on understanding the mechanisms that might lead to malignant transformation of endometriosis so as to help identify subsets of women at increased risk of ovarian cancer. FUNDING: Ovarian Cancer Research Fund, National Institutes of Health, California Cancer Research Program, California Department of Health Services, Lon V Smith Foundation, European Community's Seventh Framework Programme, German Federal Ministry of Education and Research of Germany, Programme of Clinical Biomedical Research, German Cancer Research Centre, Eve Appeal, Oak Foundation, UK National Institute of Health Research, National Health and Medical Research Council of Australia, US Army Medical Research and Materiel Command, Cancer Council Tasmania, Cancer Foundation of Western Australia, Mermaid 1, Danish Cancer Society, and Roswell Park Alliance Foundation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“endometrioid cancer (OR 2.21)”
From Clear cell carcinoma arising from abdominal wall endometriosis – Brief report and review of the literature (2017) · cites this paper as Pearce et al. (2012)
In the citing paper
“It is becoming clear that epigenetics and genomic instability associated with the particular microenvironment of endometriosis characterized by oxidative stress, inflammatory process and high estrogen levels contribute to the process of malignant transformation of endometriosis (Pearce et al., 2012, Nezhat et al., 2014).”
From Clear cell carcinoma arising from abdominal wall endometriosis – Brief report and review of the literature (2017) · cites this paper as Pearce et al., 2012
In the citing paper
“and low-grade serous invasive ovarian cancers (OR 2.21).”
From Clear cell carcinoma arising from abdominal wall endometriosis – Brief report and review of the literature (2017) · cites this paper as Pearce et al. (2012)
In the citing paper
“Pearce et al. (2012), concluded that self-reported endometriosis was associated with significantly increased risk for CCC [odds ratio (OR) 3.05]”
From Clear cell carcinoma arising from abdominal wall endometriosis – Brief report and review of the literature (2017) · cites this paper as Pearce et al. (2012)
In the citing paper
“Pearce et al. summarized 13 case-control studies and reported the highest odds ratio of 3.05 for clear cell carcinoma, followed by LG-serous (2.11) and endometrioid carcinoma (2.04) in patients with endometriosis [9].”
From Malignancies Associated with Extraovarian Endometriosis: A Literature Review (2021) · cites this paper as [9]
In the citing paper
“Malignant transformation of ovarian endometriosis has been well documented.”
From Malignancies Associated with Extraovarian Endometriosis: A Literature Review (2021) · cites this paper as [9]
In the citing paper
“In population-based studies, the incidence of ovarian cancer in patients with a history of ovarian endometriosis is 1.35-1.49times greater compared with those without this history [9,10].”
From Malignancies Associated with Extraovarian Endometriosis: A Literature Review (2021) · cites this paper as [9]
In the citing paper
“Of these, we observed associations with multiple diseases or traits, including epithelial ovarian cancer21, low-density lipoprotein cholesterol22, coronary heart disease23, luteinizing hormone and follicle-stimulating hormone levels, and age at onset for menopause24.”
From Meta-analysis identifies five novel loci associated with endometriosis highlighting key genes involved in hormone metabolism (2017) · cites this paper as [21]
In the citing paper
“Most recently, in a study of 13 226 controls and 7911 women with invasive ovarian cancer, self-reported endometriosis was associated with a significantly increased risk of clear-cell, low-grade serous, and endometrioid invasive ovarian cancers.”
From Defining Future Directions for Endometriosis Research: Workshop Report From the 2011 World Congress of Endometriosis in Montpellier, France (2013) · cites this paper as [118]
In the citing paper
“No association was noted between endometriosis and risk of mucinous or high-grade serous invasive ovarian cancer or borderline tumors of either subtype.118”
From Defining Future Directions for Endometriosis Research: Workshop Report From the 2011 World Congress of Endometriosis in Montpellier, France (2013) · cites this paper as [118]
In the citing paper
“Endometriosis and ovarian cancer have been linked by a number of studies.”
From Defining Future Directions for Endometriosis Research: Workshop Report From the 2011 World Congress of Endometriosis in Montpellier, France (2013) · cites this paper as [118]
In the citing paper
“which have been (suggested to be) associated with endometriosis or its constituting symptoms in epidemiologic studies (51–54).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
Kurman, R. J., & Shih, I. (2010) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181cf3d79 · Cited by 1,890
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Wiegand, K. C., Shah, S. P., Al-Agha, O. M., Zhao, Y., Tse, K., Zeng, T., Senz, J., McConechy, M. K., Anglesio, M. S., Kalloger, S. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1008433 · Cited by 1,712
Self-citationEskenazi, B., & Warner, M. L. (1997) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70302-8 · Cited by 1,617
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm
Kurman, R. J., & Shih, I. (2011) · Human Pathology · doi:10.1016/j.humpath.2011.03.003 · Cited by 1,099
Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events
Bradburn, M. J., Deeks, J. J., Berlin, J. A., & Russell Localio, A. (2007) · Statistics in Medicine · doi:10.1002/sim.2528 · Cited by 938
Ovarian Tumors in a Cohort of Infertile Women
Rossing, M. A., Daling, J. R., Weiss, N. S., Moore, D. E., & Self, S. G. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409223311204 · Cited by 721
Self-citationCancer risk after a hospital discharge diagnosis of endometriosis
Brinton, L. A., Gridley, G., Persson, I. R., Baron, J. A., & Bergqvist, A. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70550-7 · Cited by 549
Infertility, Fertility Drugs, and Ovarian Cancer: A Pooled Analysis of Case-Control Studies
Ness, R. B. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.3.217 · Cited by 425
Self-citationRisk of cancer after use of fertility drugs with in-vitro fertilisation
Venn, A., Watson, L., Bruinsma, F., Giles, G. G., & Healy, D. (1999) · The Lancet · doi:10.1016/s0140-6736(99)05203-4 · Cited by 368
Endometriosis and the risk of cancer with special emphasis on ovarian cancer
Melin, A., Sparén, P., Persson, I., & Bergqvist, A. (2006) · Human Reproduction · doi:10.1093/humrep/dei462 · Cited by 306
Cited by
Sorted by citations
Ovarian cancer statistics, 2018
Torre, L. A., Trabert, B., DeSantis, C. E., Miller, K. D., Samimi, G., Runowicz, C. D., Gaudet, M. M., Jemal, A., & Siegel, R. L. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21456 · Cited by 3,492
Endometriosis: pathogenesis and treatment
Vercellini, P., Viganò, P., Somigliana, E., & Fedele, L. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.255 · Cited by 1,940
Jayson, G. C., Kohn, E. C., Kitchener, H. C., & Ledermann, J. A. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62146-7 · Cited by 1,891
ESHRE guideline: endometriosis
Becker, C. M., Bokor, A., Heikinheimo, O., Horne, A., Jansen, F., Kiesel, L., King, K., Kvaskoff, M., Nap, A., Petersen, K., et al. (2022) · Human Reproduction Open · doi:10.1093/hropen/hoac009 · Cited by 1,712
“Routine US monitoring of asymptomatic endometriosis can be considered (Maouris, 1991; Alca´zar et al. , 2005; Pearce et al. , 2012; Serati et al. , 2013).”
Epidemiology of ovarian cancer: a review
Reid Brett, M., Reid Brett, M., Permuth, J. B., Sellers Thomas, A., Permuth, J. B., & Sellers Thomas, A. (2017) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2016.0084 · Cited by 1,604
Zondervan, K. T., Becker, C. M., Koga, K., Missmer, S. A., Taylor, R. N., & Viganò, P. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0008-5 · Cited by 1,257
Rethinking mechanisms, diagnosis and management of endometriosis
Chapron, C., Marcellin, L., Borghese, B., & Santulli, P. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0245-z · Cited by 1,084
Epidemiology of epithelial ovarian cancer
Webb, P. M., & Jordan, S. J. (2016) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2016.08.006 · Cited by 998
Self-citationRisk for and consequences of endometriosis: A critical epidemiologic review
Shafrir, A. L., Farland, L. V., Shah, D. K., Harris, H. R., Kvaskoff, M., Zondervan, K., & Missmer, S. A. (2018) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2018.06.001 · Cited by 823
Ediriweera, M. K., Tennekoon, K. H., & Samarakoon, S. R. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.05.012 · Cited by 760
Endometriosis and infertility: a committee opinion
(2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.05.031 · Cited by 633
Consensus on current management of endometriosis
Johnson, N. P., Hummelshoj, L., for the World Endometriosis Society Montpellier Consortium, Abrao, M. S., Adamson, G. D., Allaire, C., Amelung, V., Andersson, E., Becker, C., Birna Árdal, K. B., et al. (2013) · Human Reproduction · doi:10.1093/humrep/det050 · Cited by 558
Wentzensen, N., Poole, E. M., Trabert, B., White, E., Arslan, A. A., Patel, A. V., Setiawan, V. W., Visvanathan, K., Weiderpass, E., Adami, H.-O., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.66.8178 · Cited by 514
Self-citationEndometriosis: a high-risk population for major chronic diseases?
Kvaskoff, M., Mu, F., Terry, K. L., Harris, H. R., Poole, E. M., Farland, L., & Missmer, S. A. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv013 · Cited by 439
Self-citationSuda, K., Nakaoka, H., Yoshihara, K., Ishiguro, T., Tamura, R., Mori, Y., Yamawaki, K., Adachi, S., Takahashi, T., Kase, H., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.037 · Cited by 414
Sapkota, Y., Steinthorsdottir, V., Morris, A. P., Fassbender, A., Rahmioglu, N., De Vivo, I., Buring, J. E., Zhang, F., Edwards, T. L., Jones, S., et al. (2017) · Nature Communications · doi:10.1038/ncomms15539 · Cited by 344
The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers
Amos, C. I., Dennis, J., Wang, Z., Byun, J., Schumacher, F. R., Gayther, S. A., Casey, G., Hunter, D. J., Sellers, T. A., Gruber, S. B., et al. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0106 · Cited by 342
Self-citationOvarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology
Morgan, R. J., Armstrong, D. K., Alvarez, R. D., Bakkum-Gamez, J. N., Behbakht, K., Chen, L.-M., Copeland, L. J., Crispens, M. A., DeRosa, M., Dorigo, O., et al. (2016) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2016.0122 · Cited by 312
Epidemiology of ovarian cancer
Gaona-Luviano, P., Medina-Gaona, L. A., & Magaña-Pérez, K. (2020) · Chinese Clinical Oncology · doi:10.21037/cco-20-34 · Cited by 308
Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis
Kim, H. S., Kim, T. H., Chung, H. H., & Song, Y. S. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.29 · Cited by 312
Endometriosis, a disease of the macrophage
Capobianco, A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00009 · Cited by 309
Endometriosis and cancer: a systematic review and meta-analysis
Kvaskoff, M., Mahamat-Saleh, Y., Farland, L. V., Shigesi, N., Terry, K. L., Harris, H. R., Roman, H., Becker, C. M., As-Sanie, S., Zondervan, K. T., et al. (2021) · Human Reproduction Update · doi:10.1093/humupd/dmaa045 · Cited by 303
Self-citationThe disparate origins of ovarian cancers: pathogenesis and prevention strategies
Karnezis, A. N., Cho, K. R., Gilks, C. B., Pearce, C. L., & Huntsman, D. D. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.113 · Cited by 303
Self-citationMcAlpine, J. N., Hanley, G. E., Woo, M. M. M., Tone, A. A., Rozenberg, N., Swenerton, K. D., Gilks, C. B., Finlayson, S. J., Huntsman, D. D., & Miller, D. M. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.01.003 · Cited by 288
Self-citationOvarian Cancer Prevention and Screening
Menon, U., Karpinskyj, C., & Gentry‐Maharaj, A. (2018) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002580 · Cited by 289
Self-citationOxidative stress and the ageing endocrine system
Vitale, G., Salvioli, S., & Franceschi, C. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.29 · Cited by 271
Angiogenesis and Its Therapeutic Opportunities
Yoo, S. Y., & Kwon, S. (2013) · Mediators of Inflammation · doi:10.1155/2013/127170 · Cited by 281
Identification of six new susceptibility loci for invasive epithelial ovarian cancer
EMBRACE, Kuchenbaecker, K. B., Collaborators, G. S., Breast Cancer Family Registry, HEBON, KConFab Investigators, Australian Cancer Study (Ovarian Cancer Investigators), Australian Ovarian Cancer Study Group, the Consortium of Investigators of Modifiers of BRCA1 and BRCA2, Ramus, S. J., et al. (2015) · Nature Genetics · doi:10.1038/ng.3185 · Cited by 250
Self-citationTrabert, B., Ness, R. B., Lo-Ciganic, W.-H., Murphy, M. A., Goode, E. L., Poole, E. M., Brinton, L. A., Webb, P. M., Nagle, C. M., Jordan, S. J., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt431 · Cited by 243
Self-citationEstrogen-progestins and progestins for the management of endometriosis
Vercellini, P., Buggio, L., Berlanda, N., Barbara, G., Somigliana, E., & Bosari, S. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.10.022 · Cited by 243
S ociety of G ynecologic O ncology recommendations for the prevention of ovarian cancer
Walker, J. L., Powell, C. B., Chen, L.-M., Carter, J., Bae-Jump, V. L., Parker, L. P., Borowsky, M. E., & Gibb, R. K. (2015) · Cancer · doi:10.1002/cncr.29321 · Cited by 250
Vitonis, A. F., Vincent, K., Rahmioglu, N., Fassbender, A., Buck Louis, G. M., Hummelshoj, L., Giudice, L. C., Stratton, P., Adamson, G. D., Becker, C. M., et al. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.07.1244 · Cited by 236
Self-citationEndometriosis and Risk of Coronary Heart Disease
Mu, F., Rich-Edwards, J., Rimm, E. B., Spiegelman, D., & Missmer, S. A. (2016) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.115.002224 · Cited by 235
“(48) Although oophorectomy confers obvious prevention for ovarian cancer, with which endometriosis has been associated (49), CHD is the leading cause of mortality and morbidity in women in the US and UK.”
Essential Epidemiology: An Introduction for Students and Health Professionals
Webb, P. M., & Bain, C. (2012) · Cited by 209
Self-citationPI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer
Li, H., Zeng, J., & Shen, K. (2014) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-014-3377-3 · Cited by 206
Single-cell transcriptomic analysis of endometriosis
Fonseca, M. A., Haro, M., Wright, K. N., Lin, X., Abbasi, F., Sun, J. K., Hernández, L., Orr, N. L., Hong, J., Choi-Kuaea, Y., et al. (2023) · Nature Genetics · doi:10.1038/s41588-022-01254-1 · Cited by 206
Self-citationPlasma MicroRNAs as Novel Biomarkers for Endometriosis and Endometriosis-Associated Ovarian Cancer
Suryawanshi, S., Vlad, A. M., Lin, H.-M., Mantia-Smaldone, G., Laskey, R., Lee, M., Lin, Y., Donnellan, N., Klein-Patel, M., Lee, T., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2726 · Cited by 197
Update on biomarkers for the detection of endometriosis
Fassbender, A., Burney, R. O., F. O, D., D’Hooghe, T., & Giudice, L. (2015) · BioMed Research International · doi:10.1155/2015/130854 · Cited by 195
“Endometriosis is the third leading cause of hysterectomy in the United States [15], and increasing evidence exists for the malignant transformation of ovarian endometriomas to ovarian cancer, particularly the clear cell and endometrioid subtypes [16].”
Medical treatment of endometriosis-related pain
Vercellini, P., Buggio, L., Frattaruolo, M. P., Borghi, A., Dridi, D., & Somigliana, E. (2018) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2018.01.015 · Cited by 188
Endometriosis: where are we and where are we going?
Greene, A. D., Lang, S. A., Kendziorski, J. A., Sroga-Rios, J. M., Herzog, T. J., & Burns, K. A. (2016) · Reproduction · doi:10.1530/rep-16-0052 · Cited by 187
New insights in the pathophysiology of ovarian cancer and implications for screening and prevention
Nezhat, F. R., Apostol, R., NEZHAT, C. R., & Pejovic, T. B. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.03.044 · Cited by 181
Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden
Anglesio, M. S., Bashashati, A., Wang, Y. K., Senz, J., Ha, G., Yang, W., Aniba, R., Prentice, L., Farahani, H., Chang, H. L., et al. (2015) · The Journal of Pathology · doi:10.1002/path.4516 · Cited by 178
Self-citationEndometriosis Typology and Ovarian Cancer Risk
Barnard, M. E., Farland, L. V., Yan, B., Wang, J., Trabert, B. L., Doherty, J. A., Meeks, H., Madsen, M., Guinto, E., Collin, L. J., et al. (2024) · JAMA · doi:10.1001/jama.2024.9210 · Cited by 179
Self-citationEndometriosis-Associated Ovarian Cancer: A Review of Pathogenesis
Worley, M. J., Welch, W., Berkowitz, R. S., & Ng, S. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14035367 · Cited by 177
Samartzis, E. P., Noske, A., Dedes, K. J., Fink, D. A., & Imesch, P. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140918824 · Cited by 180
Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies
Sieh, W., Salvador, S., McGuire, V. M., Weber, R. P., Terry, K. L., Rossing, M. A., Risch, H. A., Wu, A. H., Webb, P. M., Moysich, K. B., et al. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dyt042 · Cited by 177
Self-citationAyhan, A., Mao, T., Seckin, T. A., Wu, C., Guan, B., Ogawa, H., Futagami, M., Mizukami, H., Yokoyama, Y., Kurman, R. J., et al. (2012) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e31826b5dcc · Cited by 167
Shen, H., Fridley, B. L., Song, H., Lawrenson, K., Cunningham, J. M., Ramus, S. J., Cicek, M. S., Tyrer, J. P., Stram, D. A., Larson, M. C., et al. (2013) · Nature Communications · doi:10.1038/ncomms2629 · Cited by 164
Self-citationGadducci, A., Multinu, F., Cosio, S., Carinelli, S. G., Ghioni, M., & Aletti, G. D. (2021) · Gynecologic Oncology · doi:10.1016/j.ygyno.2021.06.033 · Cited by 160
Clear cell carcinoma of the ovary: a clinical and molecular perspective
Iida, Y., Okamoto, A., Hollis, R. L., Gourley, C., & Herrington, C. S. (2020) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2020-001656 · Cited by 161
Rogers, P. A. W., D’Hooghe, T. M., Fazleabas, A., Giudice, L. C., Montgomery, G. W., Petraglia, F., & Taylor, R. N. (2013) · Reproductive Sciences · doi:10.1177/1933719113477495 · Cited by 154
Louis, G. M. B., Peterson, C. M., Chen, Z., Croughan, M. S., Sundaram, R., Stanford, J. B., Varner, M. W., Kennedy, A., Giudice, L. C., Fujimoto, V. Y., et al. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.03.026 · Cited by 149
Endocrine disrupting chemicals and endometriosis
Smarr, M. M., Kannan, K., & Louis, G. M. B. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.06.034 · Cited by 149
Kajiyama, H., Suzuki, S., Yoshihara, M., Tamauchi, S., Yoshikawa, N., Niimi, K., Shibata, K., & Kikkawa, F. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.12.015 · Cited by 147
Jareid, M., Thalabard, J., Aarflot, M., Bøvelstad, H. M., Lund, E., & Braaten, T. (2018) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.02.006 · Cited by 140
The relation between endometriosis and ovarian cancer – a review
Heidemann, L. N., Hartwell, D., Heidemann, C. H., & Jochumsen, K. M. (2013) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.12255 · Cited by 143
Oncogenic mutations in histologically normal endometrium: the new normal?
Lac, V., Nazeran, T. M., Tessier‐Cloutier, B., Aguirre-Hernández, R., Albert, A., Lum, A. M., Khattra, J. S., Praetorius, T., Mason, M., Chiu, D. S., et al. (2019) · The Journal of Pathology · doi:10.1002/path.5314 · Cited by 139
Self-citationOvarian cancer screening: Current status and future directions
Nash, Z., & Menon, U. (2020) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2020.02.010 · Cited by 147
Self-citationCYP1B1 and hormone-induced cancer
Gajjar, K. B., Martin‐Hirsch, P. L., & Martin, F. L. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.04.021 · Cited by 140
Machida, H., Matsuo, K., Yamagami, W., Ebina, Y., Kobayashi, Y., Tabata, T., Kanauchi, M., Nagase, S., Enomoto, T., & Mikami, M. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2019.03.243 · Cited by 137
Natanzon, Y., Goode, E. L., & Cunningham, J. M. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.08.003 · Cited by 138
Self-citationRisk of Gynecologic Cancer According to the Type of Endometriosis
Saavalainen, L., Lassus, H. J., But, A., Tiitinen, A. E., Härkki, P., Gissler, M., Pukkala, ., & Heikinheimo, O. (2018) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002624 · Cited by 136
Endometriosis: The Role of Iron Overload and Ferroptosis
Ng, S., Norwitz, S. G., Taylor, H. S., & Norwitz, E. R. (2020) · Reproductive Sciences · doi:10.1007/s43032-020-00164-z · Cited by 136
Kok, V. C., Tsai, H.-J., Su, C.-F., & Lee, C.-K. (2015) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000454 · Cited by 132
Suryawanshi, S., Huang, X., Elishaev, E., Budiu, R. A., Zhang, L., Kim, S., Donnellan, N. M., Mantia-Smaldone, G. M., Ma, T., Tseng, G. C., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1338 · Cited by 130
Endometriosis and risks for ovarian, endometrial and breast cancers: A nationwide cohort study
Mogensen, J. B., Kjær, S. K., Mellemkjær, L., & Jensen, A. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.07.095 · Cited by 130
Self-citationHormone response in ovarian cancer: time to reconsider as a clinical target?
Modugno, F., Laskey, R. A., Smith, A. L., Andersen, C. L., Haluska, P., & Oesterreich, S. (2012) · Endocrine Related Cancer · doi:10.1530/erc-12-0175 · Cited by 126
Endometriosis and risk of ovarian cancer: what do we know?
Králíčková, M., Laganà, A. S., Ghezzi, F., & Větvička, V. (2019) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-019-05358-8 · Cited by 125
Characterization of Ovarian Cancer Cell Lines as In Vivo Models for Preclinical Studies
Hernandez, L., Kim, M. K., Lyle, L. T., Bunch, K. P., House, C. D., Ning, F., Noonan, A. M., & Annunziata, C. M. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.05.028 · Cited by 121
Vitale, S. G., Capriglione, S., Peterlunger, I., Rosa, V. L. L., Vitagliano, A., Noventa, M., Valenti, G., Sapia, F., Angioli, R., Lopez, S., et al. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/7924021 · Cited by 125
Pathogenesis and the Role of ARID1A Mutation in Endometriosis-related Ovarian Neoplasms
Maeda, D., & Shih, I. (2012) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e31827bc24d · Cited by 121
Reproductive characteristics in relation to ovarian cancer risk by histologic pathways
Merritt, M. A., Pari, M. D., Vitonis, A. F., Titus, L. J., Cramer, D. W., & Terry, K. L. (2013) · Human Reproduction · doi:10.1093/humrep/des466 · Cited by 120
Self-citationResearch advances in endometriosis-related signaling pathways: A review
Zhang, M., Xu, T., Tong, D., Li, S., Yu, X., Liu, B., Jiang, L., & Liu, K. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114909 · Cited by 131
Chen, Y., Pei, H., Chang, Y., Chen, M., Wang, H., Xie, H., & Yao, S. (2014) · Journal of Ovarian Research · doi:10.1186/s13048-014-0108-0 · Cited by 116
Surrey, E. S., Soliman, A. M., Johnson, S. J., Davis, M. R., Castelli‐Haley, J., & Snabes, M. C. (2018) · Journal of Women s Health · doi:10.1089/jwh.2017.6432 · Cited by 115
Risks of conservative management in women with ovarian endometriomas undergoing IVF
Somigliana, E., Benaglia, L., Paffoni, A., Busnelli, A., Viganò, P., & Vercellini, P. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv012 · Cited by 114
Park, H. K., Ruterbusch, J. J., & Coté, M. L. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-0290 · Cited by 114
Sung, P., Chang, Y., Chao, K.-C., & Chuang, C.-M. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.02.016 · Cited by 112
Endometriosis-associated Malignancy
Krawczyk, N., Banys-Paluchowski, M., Schmidt, D., Ulrich, U., & Fehm, T. (2016) · Geburtshilfe und Frauenheilkunde · doi:10.1055/s-0035-1558239 · Cited by 107
Tumor-Associated Macrophages (TAMs): A Critical Activator In Ovarian Cancer Metastasis
Yin, M., Shen, J., Yu, S., Jing, F., Zhu, X., Zhao, J., Zhai, L., Sadhukhan, A., & Zhou, J. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s216355 · Cited by 108
Microarray Glycoprofiling of CA125 Improves Differential Diagnosis of Ovarian Cancer
Chen, K., Gentry‐Maharaj, A., Burnell, M., Steentoft, C., Marcos-Silva, L., Mandel, U., Jacobs, I. J., Dawnay, A., Menon, U., & Blixt, O. (2013) · Journal of Proteome Research · doi:10.1021/pr3010474 · Cited by 111
Self-citationDawson, A., Llauradó Fernandez, M., Anglesio, M., Yong, P. J., & Carey, M. S. (2018) · ecancermedicalscience · doi:10.3332/ecancer.2018.803 · Cited by 106
Genomic landscape of ovarian clear cell carcinoma via whole exome sequencing
Kim, S. I., Lee, J. W., Lee, M., Kim, H. S., Chung, H. H., Kim, J., Park, N. H., Song, Y. S., & Seo, J. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.12.005 · Cited by 106
Yarmolinsky, J., Relton, C. L., Lophatananon, A., Muir, K. R., Menon, U., Gentry‐Maharaj, A., Walther, A., Zheng, J., Fasching, P. A., Zheng, W., et al. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1002893 · Cited by 107
Self-citationBrinton, L. A., Trabert, B. L., Shalev, V., Lunenfeld, E., Sella, T., & Chodick, G. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.12.029 · Cited by 104
Epithelial Mutations in Endometriosis: Link to Ovarian Cancer
Bulun, S. E., Wan, Y., & Matei, D. E. (2019) · Endocrinology · doi:10.1210/en.2018-00794 · Cited by 105
Challenges and Opportunities in Studying the Epidemiology of Ovarian Cancer Subtypes
Doherty, J. A., Peres, L. C., Wang, C., Way, G. P., Greene, C. S., & Schildkraut, J. M. (2017) · Current Epidemiology Reports · doi:10.1007/s40471-017-0115-y · Cited by 104
Self-citationMolecular profiling and molecular classification of endometrioid ovarian carcinomas
Cybulska, P., Paula, A. D. C., Tseng, J. H., Leitão, M. M., Bashashati, A., Huntsman, D. D., Nazeran, T. M., Aghajanian, C. A., Abu‐Rustum, N. R., DeLair, D. F., et al. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2019.07.012 · Cited by 101
Self-citationOwens, G. L., Gajjar, K. B., Trevisan, J., Fogarty, S. W., Taylor, S., Gama‐Rose, B. D., Martin‐Hirsch, P. L., & Martin, F. L. (2013) · Journal of Biophotonics · doi:10.1002/jbio.201300157 · Cited by 100
Iatrogenic endometriosis harbors somatic cancer-driver mutations
Lac, V, Verhoef, L., Aguirre-Hernandez, R., Nazeran, T. M., Tessier-Cloutier, B., Praetorius, T., Orr, N. L., Noga, H., Lum, A., Khattra, J., et al. (2019) · Human Reproduction · doi:10.1093/humrep/dey332 · Cited by 99
Self-citationTai, F.-W., Chang, C. Y., Chiang, J., Lin, W.-C., & Wan, L. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7110379 · Cited by 100
Tarín, J. J., García‐Pérez, M. Á., Hamatani, T., & Cano, A. (2015) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-015-0029-9 · Cited by 99
Kim, S. J., Rosen, B. P., Fan, I., Ivanova, A., McLaughlin, J. R., Risch, H. A., Narod, S. A., & Kotsopoulos, J. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.35 · Cited by 97
Self-citationCancer-associated mutations in endometriosis: shedding light on the pathogenesis and pathophysiology
Guo, S.-W. (2020) · Human Reproduction Update · doi:10.1093/humupd/dmz047 · Cited by 96
Saraswat, L., Ayansina, D., Cooper, K. G., Bhattacharya, S., Horne, A. W., & Bhattacharya, S. (2017) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.14793 · Cited by 95
Cochrane, D. R., Tessier‐Cloutier, B., Lawrence, K. M., Nazeran, T. M., Karnezis, A. N., Salamanca, C. M., Cheng, A. S., McAlpine, J. N., Hoang, L. N., Gilks, C. B., et al. (2017) · The Journal of Pathology · doi:10.1002/path.4934 · Cited by 94
Self-citationCharacteristics of clear cell ovarian cancer arising from endometriosis: A two center cohort study
Scarfone, G., Bergamini, A., Noli, S. A., Villa, A., Cipriani, S., Taccagni, G., Viganò, P., Candiani, M., Parazzini, F., & Mangili, G. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.03.017 · Cited by 92
Genetic epidemiology of ovarian cancer and prospects for polygenic risk prediction
Jones, M. R., Kamara, D., Karlan, B. Y., Pharoah, P. D. P., & Gayther, S. A. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.10.001 · Cited by 92
Self-citationThe role of fertility preservation in patients with endometriosis
Carrillo, L. I. V., Seidman, D. S., Cittadini, E., & Meirow, D. (2016) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-016-0646-z · Cited by 91
Rasmussen, C. B., Kjær, S. K., Albieri, V., Bandera, E. V., Doherty, J. A., Høgdall, E. V. S., Webb, P. M., Jordan, S. J., Rossing, M. A., Wicklund, K. G., et al. (2016) · American Journal of Epidemiology · doi:10.1093/aje/kww161 · Cited by 91
Self-citation
Metadata
- Authors
- Pearce, C. L., Templeman, C., Rossing, M. A., Lee, A., Near, A. M., Webb, P. M., Nagle, C. M., Doherty, J. A., Cushing-Haugen, K. L., Wicklund, K. G., Chang-Claude, J., Hein, R., Lurie, G., Wilkens, L. R., Carney, M. E., Goodman, M. T., Moysich, K., Kjaer, S. K., Hogdall, E., Jensen, A., Goode, E. L., Fridley, B. L., Larson, M. C., Schildkraut, J. M., Palmieri, R. T., Cramer, D. W., Terry, K. L., Vitonis, A. F., Titus, L. J., Ziogas, A., Brewster, W., Anton-Culver, H., Gentry-Maharaj, A., Ramus, S. J., Anderson, A. R., Brueggmann, D., Fasching, P. A., Gayther, S. A., Huntsman, D. G., Menon, U., Ness, R. B., Pike, M. C., Risch, H., Wu, A. H., & Berchuck, A.
- Affiliations
- University of Southern California (US)
- Fred Hutch Cancer Center (US)
- Georgetown University Medical Center (US)
- QIMR Berghofer Medical Research Institute (AU)
- German Cancer Research Center (DE)
- University of Hawaiʻi at Mānoa (US)
- Roswell Park Comprehensive Cancer Center (US)
- Danish Cancer Society (DK)
- Mayo Clinic (US)
- Duke Medical Center (US)
- Brigham and Women's Hospital (US)
- Dartmouth College (US)
- University of California, Irvine (US)
- University of North Carolina at Chapel Hill (US)
- University College London (GB)
- University of California, Los Angeles (US)
- Yale University (US)
- Corresponding author
- Pearce, Celeste Leigh
- ORCID
- Pearce, Celeste Leigh
- Lee, Alice
- Near, Aimee M
- Webb, Penelope M
- Nagle, Christina M
- Doherty, Jennifer A
- Wicklund, Kristine G
- Wilkens, Lynne R
- Goodman, Marc T
- Moysich, Kirsten
- Jensen, Allan
- Goode, Ellen L
- Fridley, Brooke L
- Larson, Melissa C
- Schildkraut, Joellen M
- Cramer, Daniel W
- Terry, Kathryn L
- Titus, Linda J
- Ziogas, Argyrios
- Brewster, Wendy
- Ramus, Susan J
- Fasching, Peter A
- Gayther, Simon A
- Menon, Usha
- Pike, Malcolm C
- Risch, Harvey
- Wu, Anna H
- Berchuck, Andrew
- Venue
- The Lancet Oncology
- Publisher
- Elsevier BV
- Published
- 2012-04
- Volume
- 13
- Issue
- 4
- Pages
- 385-394
- ISSN
- 1470-2045 (ISSN-L)
- PMC
- PMC3664011
- OpenAlex
- W2125681453
- Cited by
- 939
- References
- 43
- Citations by year
- 2026: 47 · 2025: 53 · 2024: 46 · 2023: 64 · 2022: 44 · 2021: 84 · 2020: 88 · 2019: 77 · 2018: 71 · 2017: 83 · 2016: 68 · 2015: 65 · 2014: 55 · 2013: 68 · 2012: 26
- FWCI
- 79.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Lancet Oncology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- California Breast Cancer Research Program (0001389V20170, 2110200)
- Seventh Framework Programme (HEALTH-F2-2009-223175)
- University of South China
- National Institutes of Health (5R01 CA074850, CA14089, CA17054, CA58860, CA61132, CA92044, N01 CN67001, N01 PC35137, N01 PC67010, P50 CA105009, P50 CA136393, PSA 042205, R01 CA112523, R01 CA122443, R01 CA126841, R01 CA136891, R01 CA54419, R01 CA58598, R01 CA61107, R01 CA76016, R01 CA87538, R01 CA95023, R03 CA113148)
- Medical Research and Materiel Command (DAMD 170110729, DAMD17-02-1-0669, W81XWH0610220, W81XWH1010280)
- Oak Foundation
- Lon V. Smith Foundation (LVS 39420)
- California Department of Public Health (050E8709)
- Roswell Park Alliance Foundation, Roswell Park Cancer Institute
- Kræftens Bekæmpelse
- Deutsches Krebsforschungszentrum
- National Health and Medical Research Council (199600)
- Cancer Council Tasmania
- American University of Sharjah
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Keywords
- endometriosis, ovarian cancer, histological subtypes, ovarian clear cell carcinoma, low-grade serous ovarian cancer, endometrioid ovarian cancer, mucinous ovarian carcinoma, high-grade serous ovarian cancer, borderline ovarian tumors, cancer risk factors, oral contraceptive use, parity, tumor stage and grade, Ovarian Cancer Association Consortium
- MeSH terms
- Aged, Aged, 80 and over, Endometriosis, Ethnicity, Female, Humans, Middle Aged, Neoplasm Invasiveness, Neoplasm Staging, Ovarian Neoplasms, Risk Factors, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
